Evidence map›Paper›PMID 24623139›Full record

ArticleJournal of pharmaceutical sciences2014

Protein quantity on the air-solid interface determines degradation rates of human growth hormone in lyophilized samples.

Yemin Xu, Pawel Grobelny, Alexander Von Allmen, Korben Knudson, Michael Pikal, John F Carpenter, Theodore W Randolph

Abstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Stabilization of proteins in solid form.Advanced drug delivery reviews · 2015
    Review
  5. Long-term storage of lyophilized liposomal formulations.Journal of pharmaceutical sciences · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yemin XuCenter for Pharmaceutical Biotechnology, Department of Biochemistry, University of Colorado, Boulder, Colorado, 80309.
Pawel Grobelny
Alexander Von Allmen
Korben Knudson
Michael Pikal
John F Carpenter
Theodore W Randolph

Funding

Biotechnology Research Partnerships Renewal: Aggregation of Therapeutic ProteinsR01EB006006 · NIBIB · UNIVERSITY OF COLORADO · PI RANDOLPH, THEODORE W · 2006 to 2017
$7.2M
NIBIB NIH HHS R01 EB006006NIBIB NIH HHS R01 EB006398
6 · The paper itself

Abstract

Recombinant human growth hormone (rhGH) was lyophilized with various glass-forming stabilizers, employing cycles that incorporated various freezing and annealing procedures to manipulate glass formation kinetics, associated relaxation processes, and glass-specific surface areas (SSAs). The secondary structure in the cake was monitored by infrared and in reconstituted samples by circular dichroism. The rhGH concentrations on the surface of lyophilized powders were determined from electron spectroscopy for chemical analysis. Glass transition temperature (Tg ), SSAs, and water contents were determined immediately after lyophilization. Lyophilized samples were incubated at 323 K for 16 weeks, and the resulting extents of rhGH aggregation, oxidation, and deamidation were determined after rehydration. Water contents and Tg were independent of lyophilization process parameters. Compared with samples lyophilized after rapid freezing, rhGH in samples that had been annealed in frozen solids prior to drying, or annealed in glassy solids after secondary drying retained more native-like protein secondary structure, had a smaller fraction of the protein on the surface of the cake, and exhibited lower levels of degradation during incubation. A simple kinetic model suggested that the differences in the extent of rhGH degradation during storage in the dried state between different formulations and processing methods could largely be ascribed to the associated levels of rhGH at the solid-air interface after lyophilization.

Indexed as

Chemistry, PharmaceuticalCircular DichroismDrug StabilityFreeze DryingGlassHuman Growth HormoneHumansPowdersProtein Structure, SecondaryRecombinant ProteinsTransition TemperatureWaterHuman Growth HormonePowdersRecombinant ProteinsWaterannealinggrowth hormonelyophilizationmobilityprotein formulationprotein structurespecific surface areastabilitysurface degradation

Identifiers

PMID24623139
PMCPMC4049081

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.